Beverly Wilshire Ltd. Completes Consideration Share Issuance for Major Healthcare Asset Acquisition

Key Points from the Report

• Completion of Share Issuance: On 17 December 2025, Beverly Wilshire Ltd. (“the Company”) completed the issuance of consideration shares as part payment for the acquisition of the second floor of Tower A of Nobel Healthcare Park from KL Wellness City (H) Sdn Bhd.
• Details of the Share Issuance: The Company has allotted and issued 186,565,970 new Consideration Shares at an issue price of S\$0.014 per share, representing a significant transaction in the Company’s equity structure.
• Increase in Share Capital: Following the issuance, the total number of shares has increased from 965,432,421 to 1,151,998,391.
• Listing and Quotation: The newly issued Consideration Shares are expected to commence trading on the Catalist of the Singapore Exchange (SGX-ST) from 9:00 a.m. on 18 December 2025.
• Share Status: The Consideration Shares are fully paid, free from any encumbrances, and rank pari passu with existing shares, except they are not entitled to any dividend, right, allotment, or other distributions with a record date on or before the issuance date.

Important Information for Shareholders

• Potential Price Sensitivity:
  • The completion of this asset acquisition and the large-scale share issuance may have a material impact on the Company’s future financials, asset base, and earnings potential.
  • The significant increase in share capital could affect the share price in the short term due to potential dilution for existing shareholders, but is also a signal of the Company’s growth ambitions and expansion in the healthcare real estate sector.
• Cautionary Advice:
  • The Company has advised shareholders and potential investors to exercise caution when trading the Company’s shares and to monitor further announcements closely.
  • Investors are encouraged to consult with professionals if they are uncertain about the implications of these developments.

Additional Details

• Transaction Background: The share issuance forms part of the consideration for the acquisition of the second floor of Tower A of Nobel Healthcare Park, a strategic asset in a prominent healthcare hub, supporting the Company’s continued growth and diversification.
• Regulatory Status: The Company previously obtained the necessary listing and quotation notice from SGX-ST, and the transaction follows all required disclosure and regulatory review processes.
• Corporate Governance: The announcement was made by Dato’ Ng Tian Sang @ Ng Kek Chuan, Deputy Chairman and Chief Executive Officer, and reviewed by the Company’s Sponsor, Evolve Capital Advisory Private Limited. However, the SGX-ST has not examined or approved the content of the announcement.

Conclusion

This acquisition and the associated share issuance represent a substantial step in Beverly Wilshire Ltd.’s expansion strategy and could drive future growth in the healthcare real estate market. Shareholders should note the potential for immediate share price movement due to the dilution effect, as well as the longer-term prospects of the enlarged asset base.

Disclaimer

This article is for informational purposes only and does not constitute investment advice. Investors are strongly advised to read official Company announcements and consult with their professional advisers before making any investment decisions. The Singapore Exchange and the Company’s Sponsor do not take responsibility for the content herein.

View B Wilshire Ltd Historical chart here